MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on August 31, 2004; DOI: 10.1124/mol.104.002758


0026-895X/04/6606-1361-1371$20.00
Mol Pharmacol 66:1361-1371, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.002758v1
66/6/1361    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blancafort, P.
Right arrow Articles by Barbas, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blancafort, P.
Right arrow Articles by Barbas, C. F., III
Minireview

Designing Transcription Factor Architectures for Drug Discovery

Pilar Blancafort, David J. Segal, and Carlos F. Barbas, III

Department of Molecular Biology, The Scripps Research Institute, La Jolla, California (P.B., C.F.B.); and Department of Pharmacology and Toxicology, University of Arizona College of Pharmacy, Tucson, Arizona (D.S.)

Recent advances in the design, selection, and engineering of DNA binding proteins have led to the emerging field of designer transcription factors (TFs). Modular DNA-binding protein domains can be assembled to recognize a given sequence of a DNA in a regulatory region of a targeted gene. TFs can be readily prepared by linking the DNA-binding protein to a variety of effector domains that mediate transcriptional activation or repression. Furthermore, the interaction between the TF and the genomic DNA can be regulated by several approaches, including chemical regulation by a variety of small molecules. Genome-wide single target specificity has been demonstrated using arrays of sequence-specific zinc finger (ZF) domains, polydactyl proteins. Any laboratory today can easily construct polydactyl ZF proteins by linkage of predefined ZF units that recognize specific triplets of DNA. The potential of this technology to alter the transcription of specific genes, to discover new genes, and to induce phenotypes in cells and organisms is now being applied in the areas of molecular therapeutics, pharmacology, biotechnology, and functional genomics.


Received May 14, 2004; accepted August 25, 2004

Address correspondence to: Carlos F. Barbas III, Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037. E-mail: carlos{at}scripps.edu




This article has been cited by other articles:


Home page
J. Virol.Home page
K. A. Zimmerman, K. P. Fischer, M. A. Joyce, and D. L. J. Tyrrell
Zinc Finger Proteins Designed To Specifically Target Duck Hepatitis B Virus Covalently Closed Circular DNA Inhibit Viral Transcription in Tissue Culture
J. Virol., August 15, 2008; 82(16): 8013 - 8021.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. Y. Lee, B. H. Sung, B. J. Yu, J. H. Lee, S. H. Lee, M. S. Kim, M. D. Koob, and S. C. Kim
Phenotypic engineering by reprogramming gene transcription using novel artificial transcription factors in Escherichia coli
Nucleic Acids Res., July 18, 2008; (2008) gkn449v1.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
V. Dixit and R. L. Juliano
Selective Killing of Smad4-Negative Tumor Cells via a Designed Repressor Strategy
Mol. Pharmacol., July 1, 2008; 74(1): 289 - 297.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
A. G. Rao
The Outlook for Protein Engineering in Crop Improvement
Plant Physiology, May 1, 2008; 147(1): 6 - 12.
[Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
P. Blancafort, M. P. Tschan, S. Bergquist, D. Guthy, A. Brachat, D. A. Sheeter, B. E. Torbett, D. Erdmann, and C. F. Barbas III
Modulation of drug resistance by artificial transcription factors
Mol. Cancer Ther., March 1, 2008; 7(3): 688 - 697.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Wiznerowicz, J. Jakobsson, J. Szulc, S. Liao, A. Quazzola, F. Beermann, P. Aebischer, and D. Trono
The Kruppel-associated Box Repressor Domain Can Trigger de Novo Promoter Methylation during Mouse Early Embryogenesis
J. Biol. Chem., November 23, 2007; 282(47): 34535 - 34541.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
B. I. Lindhout, P. Fransz, F. Tessadori, T. Meckel, P. J.J. Hooykaas, and B. J. v. d. Zaal
Live cell imaging of repetitive DNA sequences via GFP-tagged polydactyl zinc finger proteins
Nucleic Acids Res., August 17, 2007; (2007) gkm618v1.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
D. Nguyen, M. Bail, G. Pesant, V. N. Dupont, E. Rouault, J. Deschenes, W. Rocha, G. Melancon, S. V. Steinberg, and S. Mader
Rational design of an estrogen receptor mutant with altered DNA-binding specificity
Nucleic Acids Res., May 11, 2007; 35(10): 3465 - 3477.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Minczuk, M. A. Papworth, P. Kolasinska, M. P. Murphy, and A. Klug
Sequence-specific modification of mitochondrial DNA using a chimeric zinc finger methylase
PNAS, December 26, 2006; 103(52): 19689 - 19694.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
M. Heinemann and S. Panke
Synthetic biology--putting engineering into biology
Bioinformatics, November 15, 2006; 22(22): 2790 - 2799.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Morton, M. W. Davis, E. M. Jorgensen, and D. Carroll
Induction and repair of zinc-finger nuclease-targeted double-strand breaks in Caenorhabditis elegans somatic cells
PNAS, October 31, 2006; 103(44): 16370 - 16375.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. G. Mandell and C. F. Barbas III
Zinc Finger Tools: custom DNA-binding domains for transcription factors and nucleases.
Nucleic Acids Res., July 1, 2006; 34(Web Server issue): W516 - W523.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
M. Acar, H. Jafar-Nejad, N. Giagtzoglou, S. Yallampalli, G. David, Y. He, C. Delidakis, and H. J. Bellen
Senseless physically interacts with proneural proteins and functions as a transcriptional co-activator
Development, May 15, 2006; 133(10): 1979 - 1989.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
K. Beumer, G. Bhattacharyya, M. Bibikova, J. K. Trautman, and D. Carroll
Efficient Gene Targeting in Drosophila With Zinc-Finger Nucleases
Genetics, April 1, 2006; 172(4): 2391 - 2403.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. R. Eberhardy, J. Goncalves, S. Coelho, D. J. Segal, B. Berkhout, and C. F. Barbas III
Inhibition of Human Immunodeficiency Virus Type 1 Replication with Artificial Transcription Factors Targeting the Highly Conserved Primer-Binding Site
J. Virol., March 15, 2006; 80(6): 2873 - 2883.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
W. Tan, Z. Dong, T. A. Wilkinson, C. F. Barbas III, and S. A. Chow
Human Immunodeficiency Virus Type 1 Incorporated with Fusion Proteins Consisting of Integrase and the Designed Polydactyl Zinc Finger Protein E2C Can Bias Integration of Viral DNA into a Predetermined Chromosomal Region in Human Cells
J. Virol., February 15, 2006; 80(4): 1939 - 1948.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Dreier, R. P. Fuller, D. J. Segal, C. V. Lund, P. Blancafort, A. Huber, B. Koksch, and C. F. Barbas III
Development of Zinc Finger Domains for Recognition of the 5'-CNN-3' Family DNA Sequences and Their Use in the Construction of Artificial Transcription Factors
J. Biol. Chem., October 21, 2005; 280(42): 35588 - 35597.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. V. Lund, M. Popkov, L. Magnenat, and C. F. Barbas III
Zinc Finger Transcription Factors Designed for Bispecific Coregulation of ErbB2 and ErbB3 Receptors: Insights into ErbB Receptor Biology
Mol. Cell. Biol., October 15, 2005; 25(20): 9082 - 9091.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Blancafort, E. I. Chen, B. Gonzalez, S. Bergquist, A. Zijlstra, D. Guthy, A. Brachat, R. H. Brakenhoff, J. P. Quigley, D. Erdmann, et al.
Genetic reprogramming of tumor cells by zinc finger transcription factors
PNAS, August 16, 2005; 102(33): 11716 - 11721.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. L. Brady, S. N. Ponnampalam, M. J. Bumbulis, and D. R. Setzer
Mutations in TFIIIA That Increase Stability of the TFIIIA-5 S rRNA Gene Complex: UNUSUAL EFFECTS ON THE KINETICS OF COMPLEX ASSEMBLY AND DISSOCIATION
J. Biol. Chem., July 22, 2005; 280(29): 26743 - 26750.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
R. L. Juliano, V. R. Dixit, H. Kang, T. Y. Kim, Y. Miyamoto, and D. Xu
Epigenetic manipulation of gene expression: a toolkit for cell biologists
J. Cell Biol., June 20, 2005; 169(6): 847 - 857.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics